VP-315

· Verrica Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VP-315, covering 2025-06-18 to 2025-06-18. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma [Phase 2]